Articles by Anthony J. DeStefano, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Anthony J. DeStefano, PhD

Inside USP: US Pharmacopeia Proposes New Standard on Glass Quality

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.
Jun 2, 2012

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.

Inside USP: A Holistic Approach to Supply-Chain Integrity

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.
Mar 2, 2012

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.

Inside USP: Global Harmonization Presents Opportunities and Challenges

To keep moving forward, the Pharmacopoeial Discussion Group needs industry participation.
Jan 2, 2012

To keep moving forward, the Pharmacopoeial Discussion Group needs industry participation.

Inside USP: Adulteration and Contamination Awareness

USP is working to ensure quality standards and to increase public information.
Nov 2, 2010

USP is working to ensure quality standards and to increase public information.

Inside USP: USP Metals Testing: A Workshop Report

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.
Nov 2, 2008

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here